Aptose Biosciences Inc (APTO)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

251 CONSUMERS ROAD TORONTO, ONTARIO, CANADA M2J 4R3

Lorus Therapeutics is a biopharmaceutical company. Co. is engaged in the discovery, research and development of novel anticancer therapies with a safety profile. Co. has worked to establish a marketable anticancer product pipeline, with products in various stages of development ranging from discovery and pre-clinical to preparation for initiation of a Phase III clinical trial. Co. is considered to be in the development stage.

Data as of 2021-05-08 11:12:31 -0400
Market Cap431.263 Million Shares Outstanding88.92 Million Avg 30-day Volume1.011 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-6.78 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.91375 52-week High/Low9.0 / 3.39 Next Earnings Date2021-08-03 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from APTO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 3 0.0% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 68 67 1.49% 29 (1.74%) 29 (1.8%) 0.0%
13F shares: 48.706 Million 46.383 Million 5.01% 27.357 Million 34.408 Million -20.49%
% Ownership 54.8256 52.2104 5.01% 30.7937 38.7311 -20.49%
New Positions: 18 14 28.57% 7 6 16.67%
Increased Positions 18 31 -41.94% 8 16 -50.0%
Closed Positions 15 8 87.5% 5 3 66.67%
Reduced Positions 17 11 54.55% 10 4 150.0%
Total Calls 571.911 Thousand 257.787 Thousand 121.85% 268 Thousand 228.1 Thousand 17.49%
Total Puts 105.932 Thousand 22.512 Thousand 370.56% 69 Thousand 22.1 Thousand 212.22%
PUT/CALL Ratio 0.19 0.09 111.11% 0.26 0.1 160.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding APTO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APTO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BURGER DENIS R

  • Director
0 2021-01-04 1

PLATZER ERICH

  • Director
0 2021-01-04 1

LOEWY CAROLINE M

  • Director
0 2021-01-04 1

VINCENT MARK D.

  • Director
0 2021-01-04 1

CHOW GREGORY K. EXECUTIVE VP & CFO

  • Officer
0 2021-01-04 2

WHITEHEAD WARREN

  • Director
0 2021-01-04 3

RICE WILLIAM G. CHAIR, PRESIDENT & CEO

  • Officer
  • Director
0 2021-01-04 2

ASHE CAROL GAIL

  • Director
0 2021-01-04 1

MARANGO JOTIN SENIOR VP, CHIEF BUS. OFFICER

  • Officer
0 2021-01-04 3

BEJAR RAFAEL SR. VP, CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-04 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
APTOSE BIOSCIENCES INC APTO 2021-05-12 17:15:03 UTC -4.6788 4.7288 1800000
APTOSE BIOSCIENCES INC APTO 2021-05-12 16:45:03 UTC -4.6695 4.7195 1800000
APTOSE BIOSCIENCES INC APTO 2021-05-12 16:15:03 UTC -4.6695 4.7195 1800000
APTOSE BIOSCIENCES INC APTO 2021-05-12 15:45:02 UTC -4.6695 4.7195 1700000
APTOSE BIOSCIENCES INC APTO 2021-05-12 15:15:03 UTC -4.6695 4.7195 1700000
APTOSE BIOSCIENCES INC APTO 2021-05-12 14:45:03 UTC -4.6695 4.7195 1700000
APTOSE BIOSCIENCES INC APTO 2021-05-12 14:15:03 UTC -4.6695 4.7195 1700000
APTOSE BIOSCIENCES INC APTO 2021-05-12 13:45:03 UTC -4.6695 4.7195 1700000
APTOSE BIOSCIENCES INC APTO 2021-05-12 13:15:03 UTC -4.6695 4.7195 1600000
APTOSE BIOSCIENCES INC APTO 2021-05-12 12:45:02 UTC -4.6695 4.7195 1600000
APTOSE BIOSCIENCES INC APTO 2021-05-11 22:15:03 UTC -4.6695 4.7195 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 21:45:03 UTC -4.9557 5.0057 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 21:15:03 UTC -4.9557 5.0057 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 20:45:03 UTC -4.9557 5.0057 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 20:15:03 UTC -4.9557 5.0057 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 19:45:03 UTC -4.9557 5.0057 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 19:15:02 UTC -4.9557 5.0057 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 18:45:02 UTC -4.6732 4.7232 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 18:15:03 UTC -4.6732 4.7232 2000000
APTOSE BIOSCIENCES INC APTO 2021-05-11 17:45:03 UTC -4.6732 4.7232 2000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund APTO -3800.0 shares, $-22705.0 2021-03-31 N-PORT

Elevate your investments